(thirdQuint)A Double-Blind Placebo Controlled Trial of Riluzole in Bipolar Depression.

 The study will last 8 to 12 weeks and requires weekly visits.

 Participants will come to Johns Hopkins for a screening visit during which they will talk with a psychiatrist, answer questions about their mood and symptoms, have their blood drawn and have a brief physical exam.

 If they meet criteria for the study, any antidepressant medication that they are taking will be tapered and stopped before beginning study medications.

 Participation in the study includes free study medication, labs, and testing plus reimbursement for transportation.

 Participants will also be paid and after the study referred back to their treating psychiatrist with treatment recommendations.

.

 A Double-Blind Placebo Controlled Trial of Riluzole in Bipolar Depression@highlight

The Johns Hopkins Department of Psychiatry is conducting a research study to examine the effectiveness of riluzole in treating the depressed phase of bipolar disorder.

 This outpatient treatment study of medication or placebo will last 9-12 weeks.

 The study includes medical and psychiatric evaluations as well as time-limited medication treatment at no cost, and you will be compensated for your participation.

